JADPRO Webinar Series

Intervene With Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Discussion
Date
January 24, 2023
Speaker
Linda Perry, MS, PA-C
Abramson Cancer Center, University of Pennsylvania
Intervene With Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Discussion
Date
January 25, 2023
Speaker
Karolina Faysman, RN, MSN, AOCNP, DNP(c)
UCLA Medical Center
Intervene With Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Discussion
Date
January 26, 2023
Speaker
Abbey Blair, PA
University Hospitals Case Medical Center
Intervene With Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Discussion
Date
January 31, 2023
Speaker
Erin Kopp, DNP, ACNP-BC, BMTCN
Director of Advanced Practice, City of Hope National Medical Center
Intervene With Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Discussion
Date
February 1, 2023
Speaker
Christine Rimkus, APRN, MSN, AOCN
St. Louis University
Discussion of BRUKINSA for adult patients with CLL/SLL
Date
February 21, 2023
Speaker
Golbon Sterbis, MSN, APRN, NP-C
Nurse Practitioner, Karmanos Cancer Institute
Discussion of BRUKINSA for adult patients with CLL/SLL
Date
February 22, 2023
Speaker
Christopher Nelson, MSN, MBA, CNP
Certified Nurse Practitioner, Avera Health
LONSURF® + bevacizumab for the Treatment of 3L Metastatic Colorectal Cancer
Date
September 26, 2023
Speaker
Stacy Kepler, PharmD
Hematology Oncology Associates of Central New York
LONSURF® + bevacizumab for the Treatment of 3L Metastatic Colorectal Cancer
Date
September 28, 2023
Speaker
Kirollos Hanna, PharmD
Minnesota Oncology
LONSURF® + bevacizumab for the Treatment of 3L Metastatic Colorectal Cancer
Date
October 3, 2023
Speaker
Kirollos Hanna, PharmD
Minnesota Oncology
LONSURF® + bevacizumab for the Treatment of 3L Metastatic Colorectal Cancer
Date
October 4, 2023
Speaker
Aileen MacAndrew, NP
UCLA Health - Santa Monica, Los Angeles
LONSURF® + bevacizumab for the Treatment of 3L Metastatic Colorectal Cancer
Date
October 5, 2023
Speaker
Ann Marie Siney-Yeh, NP
UCLA Health - Santa Monica, Los Angeles